Dc Investments Management, LLC Logic Bio Therapeutics, Inc. Transaction History

Dc Investments Management, LLC

  • $117 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 06, 2019
SELL
$7.93 - $10.41 $413,739 - $543,131
-52,174 Closed
0 $0
Q4 2018

Feb 08, 2019
BUY
$7.88 - $17.98 $411,131 - $938,088
52,174 New
52,174 $543,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Dc Investments Management, LLC Portfolio

Follow Dc Investments Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dc Investments Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email